2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prevention of multidrug-resistant infections from contaminated duodenoscopes: Position Statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA).

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Patients should be informed about the benefits and risks of endoscopic retrograde cholangiopancreatography (ERCP)Only specially trained and competent personnel should carry out endoscope reprocessing.Manufacturers of duodenoscopes should provide detailed instructions on how to use and reprocess their equipment.In the case of modifications to their equipment, manufacturers should provide updated instructions for use.Detailed reprocessing protocols based on the manufacturer's instructions for use should clearly lay out the different reprocessing steps necessary for each endoscope model.Appropriate cleaning equipment should be used for duodenoscopes in compliance with the manufacturer's instructions for use. Only purpose-designed, endoscope type-specific, single-use cleaning brushes should be used, to ensure optimal cleaning. As soon as the endoscope is withdrawn from the patient, bedside cleaning should be performed, followed by leak testing, thorough manual cleaning steps, and automated reprocessing, in order to: · Remove debris from external and internal surfaces;. · Prevent any drying of body fluids, blood, or debris;. · Prevent any formation of biofilms.. In addition to the leak test, visual inspection of the distal end as well as regular maintenance of duodenoscopes should be performed according to the manufacturer's instructions for use, in order to detect any damage at an early stage.The entire reprocessing procedure in endoscope washer-disinfectors (EWDs) should be validated according to the European and International Standard, EN ISO 15883. Routine technical tests of EWDs should be performed according to the validation reports.Microbiological surveillance of a proportion of the department's endoscopes should be performed every 3 months, with the requirement that all endoscopes used in the unit are tested at least once a year.In the case of suspected endoscopy-related infection, the relevant device (e. g., endoscope, EWD) should be taken out of service until adequate corrective actions have been taken. Outbreaks should be managed by a multidisciplinary team, including endoscopy, hygiene, and microbiology experts, manufacturers, and regulatory bodies, according to national standards and/or laws. In the case of suspected multidrug-resistant organism (MDRO) outbreaks, close cooperation between the endoscopy unit and the clinical health provider is essential (including infection control departments and hospital hygienists).

          Related collections

          Author and article information

          Journal
          Endoscopy
          Endoscopy
          Georg Thieme Verlag KG
          1438-8812
          0013-726X
          Nov 2017
          : 49
          : 11
          Affiliations
          [1 ] ESGENA Scientific Secretary, Ulm, Germany.
          [2 ] Grevenbroich, Germany.
          [3 ] Olympus Europa, Hamburg, Germany.
          [4 ] University Hospital KBC-Zagreb-Rebro, Zagreb, Croatia.
          [5 ] Medical Devices Division, CBC Europe Srl, Nova Milanese (MB), Italy.
          [6 ] Gedyt Endoscopy Center, Buenos Aires, Argentina.
          [7 ] Digestive Endoscopy Unit, Catholic University, Rome, Italy.
          [8 ] 2nd Department of Internal Medicine, Katholisches Klinikum, Mainz, Germany.
          [9 ] ESGENA Past President, Birmingham, UK.
          [10 ] Department of Hygiene and Infection Prevention, Medical Center, University Hospital, Mainz, Germany.
          [11 ] Biotech Germande, Marseille, France.
          [12 ] Digestive Diseases Department, Hôpital Edouard Herriot, Lyon, France.
          [13 ] 2nd Department of Internal Medicine, Charles University Teaching Hospital, Hradec Králové, Czech Republic.
          [14 ] Institut Arnault Tzanck, St. Laurent du Var, France.
          [15 ] Microbiology and Hygiene Department, Chemische Fabrik Dr. Weigert, Hamburg, Germany.
          [16 ] St. Woolos Hospital, Newport, UK.
          [17 ] Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.
          Article
          10.1055/s-0043-120523
          29036747
          4433c5f8-7b92-4b5c-bab3-23f6f19e7927
          History

          Comments

          Comment on this article